oral tirzepatide clinical trial ‼️Obesity slots almost all filled! There are still some spots for those with diabetes available , Obesity alert 👀, This is a phase 3 clinical trial enrolling 800 adults, last about 89 Tirzepatide Oral Rapid Dissolve Sublingual

In a 68- and 72-week clinical trial studying Wegovy (2.4 mg) and Zepbound (15 mg) in patients without diabetes and with BMI 30, or BMI 27 with a weight-related condition, the average weight loss was 15% and 20%, when paired with diet and exercise changes (compared to 2.4% and 3.1%, respectively, with diet and exercise alone)

Please see Prescribing Information and Medication Guide for Wegovy

Bottom line: OnlineSemaglutide.orgs 6-month plan at $241/mo (plus $50 off the first month with code policy-lab-50 , dropping it to $191) is the lowest annualized price we found

Perkovic V, Tuttle KR, Rossing P, Mahaffey KW, Mann JFE, Bakris G, et al